TABLE 3.
Study | Random allocation | Concealment schemes | Blinding | Withdrawals and drop‐out | Total score | Interpretation |
---|---|---|---|---|---|---|
Castillo ME et al. 24 2020 | 2 | 1 | 0 | 1 | 4 | Moderate quality |
Murai IH et al. 29 2020 | 2 | 2 | 2 | 1 | 7 | High quality |
Note: Points were determined as follows: (1) random allocation: computer‐generated random numbers, 2 points; not described, 1 point; inappropriate method, 0 point; (2) allocation concealment: central randomization, sealed envelopes or similar, 2 points; not described, 1 point; inappropriate or unused, 0 point; (3) blindness: identical placebo tablets or similar, 2 point; inadequate or not described, 1 point; inappropriate or no double blinding, 0 point; and (4) withdrawals and drop‐outs: numbers and reasons are described, 1 point; not described, 0 point. The Jadad scale score ranges from 1 to 7; higher score indicates better RCT quality. If a study had a modified Jadad score >4 points, it was considered to be of high quality; if the score was 3–4 points, it was moderate quality; and if the score was <3 points, it was low quality.